View the GERN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Geron Corporation real. The current price of GERN is USD — it has increased by % in the past 24 hours. Watch Geron Corporation stock price performance more closely on the. Geron Corp (GERN) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. The 28 analysts offering price forecasts for Geron have a median target of , with a high estimate of and a low estimate of The median estimate. Analyst Price Targets ; ; Average ; Current ; High.
13 analysts offering month price forecasts for Geron Corporation (GERN) have a share price target of $ This median of share price forecast represents a. Based on short-term price targets offered by eight analysts, the average price target for Geron comes to $ The forecasts range from a low of $ to a. The average price target is $ with a high estimate of $10 and a low estimate of $ Sign in to your SmartPortfolio to see more analyst recommendations. Looking back, over the last four weeks, Geron gained percent. Over the last 12 months, its price rose by percent. Looking ahead, we forecast Geron to. The average stock forecast for Geron Corp (GERN) is USD. This price target corresponds to an upside of %. The range of stock forecasts for GERN is. Geron stock would need to gain 10,% to reach $ According to our Geron stock forecast, the price of Geron stock will not reach $ The highest. According to analysts, GERN price target is USD with a max estimate of USD and a min estimate of USD. 5 Day. % ; 1 Month. % ; 3 Month. % ; YTD. % ; 1 Year. %. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. Analyst Price Targets ; ; Average ; Current ; High. Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.
Research Geron's (Nasdaq:GERN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Find the latest Geron Corporation (GERN) stock quote, history, news and other vital information to help you with your stock trading and investing. On average, Wall Street analysts predict that Geron's share price could reach $ by Aug 9, The average Geron stock price prediction forecasts a. What is the forecast, or price target, for Geron (GERN) stock? A. Geron has a consensus price target of $ Q. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. Geron price target raised to $ from $5 at B. Riley by TipRanks Aug 09 3 1-year stock price forecast. GERN Competitors. Facts Insights Learn. Content From Our Affiliates · Geron price target raised to $ from $5 at B. · Barclays Reaffirms Their Buy Rating on Geron (GERN) August 9, TipRanks. Stock Price Forecast. The 7 analysts with month price forecasts for Geron stock have an average target of , with a low estimate of and a high.
Geron is projected to increase in value after the next headline, with the price projected to jump to or above. The average volatility of media hype impact. Geron started at outperform with $5 stock price target at Wedbush. Oct. 28 Geron started at buy with $4 stock price target at B. Riley. Jul. 28, Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ GERN will report FY earnings on 03/06/ Yearly Estimates. Geron Stock Forecast, GERN stock price prediction. Price target in 14 days: USD. The best long-term & short-term Geron share price prognosis for
Geron Corporation holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days. GERN's current price target is $ Learn why top analysts are making this stock forecast for Geron at MarketBeat. The average one-year price target for Geron Corporation is $ The forecasts range from a low of $ to a high of $ A stock's price target is the. Get the latest updates on Geron Corporation Common Stock (GERN) pre market trades, share volumes, and more Forecast Changes · Commodities -> · Gold · Copper. stock price prediction is 0 USD. The stock forecast is 0 USD for September 06, Saturday with technical analysis. Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. View today's Geron Corporation stock price and latest GERN news and analysis. Create real-time notifications to follow any changes in the live stock price. What is the Geron stock forecast? The Geron stock forecast for tomorrow is $ , which would represent a % loss compared to the current price. In the. Stock Price Forecast. The 8 analysts with month price forecasts for Geron stock have an average target of , with a low estimate of and a high. Geron price target raised to $ from $5 at B. Riley by TipRanks Aug 09 3 1-year stock price forecast. GERN Competitors. Facts Insights Learn. Geron Stock Forecast: While imetelstat is still years away from the market, it could be a blockbuster if and when it is finally approved for patient use. Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic. On average, Wall Street analysts predict that Geron's share price could reach $ by Sep 9, The average Geron stock price prediction forecasts a. 13 analysts offering month price forecasts for Geron Corporation (GERN) have a share price target of $ This median of share price forecast represents a. The 28 analysts offering price forecasts for Geron have a median target of , with a high estimate of and a low estimate of The median estimate. While ratings are subjective and will change, the latest Geron (GERN) rating was a reiterated with a price target of $ to $ The current price Geron . Get Geron Corp (GERN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Looking back, over the last four weeks, Geron gained percent. Over the last 12 months, its price rose by percent. Looking ahead, we forecast Geron to. Research Geron's (Nasdaq:GERN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Geron Corp. analyst ratings, historical stock prices, earnings estimates & actuals. GERN updated stock price target summary. Based on 7 Wall Street analysts offering 12 month price targets for Geron in the last 3 months. The average price target is € with a high forecast of € Geron Stock Forecast, GERN stock price prediction. Price target in 14 days: USD. The best long-term & short-term Geron share price prognosis for The current price of GERN is USD — it has increased by % in the past 24 hours. Watch Geron Corporation stock price performance more closely on the. The average stock forecast for Geron Corp (GERN) is USD. This price target corresponds to an upside of %. The range of stock forecasts for GERN is. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ Geron is projected to increase in value after the next headline, with the price projected to jump to or above. The average volatility of media hype impact. GERN - Geron - Stock Forecast GERN is currently covered by 6 analysts with an average price target of $ This is a potential upside of $ (%) from. See Geron Corporation (GERN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Analyst Price Targets. According to analysts, GERN price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. The average price target is $ with a high estimate of $10 and a low estimate of $ Sign in to your SmartPortfolio to see more analyst recommendations.
Barclays initiates coverage on Geron (NASDAQ:GERN) with a Overweight rating and announces Price Target of $9. BenzingaJun 10 A naive forecasting model for Geron is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the. Track Geron Corp. (GERN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. Currently, Wall Street analysts rate GERN as Very Bullish on average. Additionally, the current consensus price target from analysts is $ To see all of. Find the latest Geron Corporation (GERN) stock forecast, month price target, predictions and analyst recommendations. How much is Geron's stock price per share? (NASDAQ: GERN) Geron stock price per share is $ today (as of Sep 6, ). · What is Geron's Market Cap? (NASDAQ.
Penny Stock To Buy Today Usa | Best Quality Travel Insurance